Novartis AG’s drug Gilenia has risks that may outweigh its benefit in treating multiple sclerosis, according to U.S. regulators reviewing whether to approve the first pill to slow progression of the disease.
More...
More...
Our valued sponsor
Novartis’ Multiple Sclerosis Pill Faces FDA Review (Update1)
- Thread starter guest
- Start date
Latest Threads
-
Payment gateway for EVC (Expedia Virtual Card)- Started by diskoteka
- Replies: 0
-
-
-
-
Best place to register offshore company with nominees, privacy question?- Started by justnew
- Replies: 7
-
Common Reporting Standard / Revolut CRS
- Started by kpeter440
- Replies: 6
-
-
-
Cards with cash back for UK / EU entity ?
- Started by Alenka
- Replies: 6
